Cerebellar dysfunction and schizophrenia-like behavior in Ebp1-deficient mice
© 2022. The Author(s), under exclusive licence to Springer Nature Limited..
Cerebellar deficits with Purkinje cell (PCs) loss are observed in several neurologic disorders. However, the underlying mechanisms as to how the cerebellum is affected during development remain unclear. Here we demonstrated that specific inactivation of murine Ebp1 in the central nervous system causes a profound neuropathology characterized by reduced cerebellar volume and PCs loss with abnormal dendritic development, leading to phenotypes including motor defects and schizophrenia (SZ)-like behaviors. Loss of Ebp1 leads to untimely gene expression of Fbxw7, an E3 ubiquitin ligase, resulting in aberrant protein degradation of PTF1A, thereby eliciting cerebellar defects. Reinstatement of Ebp1, but not the Ebp1-E183Ter mutant found in SZ patients, reconstituted cerebellar architecture with increased PCs numbers and improved behavioral phenotypes. Thus, our findings indicate a crucial role for EBP1 in cerebellar development, and define a molecular basis for the cerebellar contribution to neurologic disorders such as SZ.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
---|---|
Enthalten in: |
Molecular psychiatry - 27(2022), 4 vom: 14. Apr., Seite 2030-2041 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hwang, Inwoo [VerfasserIn] |
---|
Links: |
---|
Themen: |
DNA-Binding Proteins |
---|
Anmerkungen: |
Date Completed 25.05.2022 Date Revised 25.10.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41380-022-01458-1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM336974795 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM336974795 | ||
003 | DE-627 | ||
005 | 20231225233349.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41380-022-01458-1 |2 doi | |
028 | 5 | 2 | |a pubmed24n1123.xml |
035 | |a (DE-627)NLM336974795 | ||
035 | |a (NLM)35165395 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hwang, Inwoo |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cerebellar dysfunction and schizophrenia-like behavior in Ebp1-deficient mice |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.05.2022 | ||
500 | |a Date Revised 25.10.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s), under exclusive licence to Springer Nature Limited. | ||
520 | |a Cerebellar deficits with Purkinje cell (PCs) loss are observed in several neurologic disorders. However, the underlying mechanisms as to how the cerebellum is affected during development remain unclear. Here we demonstrated that specific inactivation of murine Ebp1 in the central nervous system causes a profound neuropathology characterized by reduced cerebellar volume and PCs loss with abnormal dendritic development, leading to phenotypes including motor defects and schizophrenia (SZ)-like behaviors. Loss of Ebp1 leads to untimely gene expression of Fbxw7, an E3 ubiquitin ligase, resulting in aberrant protein degradation of PTF1A, thereby eliciting cerebellar defects. Reinstatement of Ebp1, but not the Ebp1-E183Ter mutant found in SZ patients, reconstituted cerebellar architecture with increased PCs numbers and improved behavioral phenotypes. Thus, our findings indicate a crucial role for EBP1 in cerebellar development, and define a molecular basis for the cerebellar contribution to neurologic disorders such as SZ | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a DNA-Binding Proteins |2 NLM | |
650 | 7 | |a Pa2g4 protein, mouse |2 NLM | |
650 | 7 | |a RNA-Binding Proteins |2 NLM | |
700 | 1 | |a Kim, Byeong-Seong |e verfasserin |4 aut | |
700 | 1 | |a Ko, Hyo Rim |e verfasserin |4 aut | |
700 | 1 | |a Cho, Seongbong |e verfasserin |4 aut | |
700 | 1 | |a Lee, Ho Yun |e verfasserin |4 aut | |
700 | 1 | |a Cho, Sung-Woo |e verfasserin |4 aut | |
700 | 1 | |a Ryu, Dongryeol |e verfasserin |4 aut | |
700 | 1 | |a Shim, Sungbo |e verfasserin |4 aut | |
700 | 1 | |a Ahn, Jee-Yin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Molecular psychiatry |d 1997 |g 27(2022), 4 vom: 14. Apr., Seite 2030-2041 |w (DE-627)NLM09062694X |x 1476-5578 |7 nnns |
773 | 1 | 8 | |g volume:27 |g year:2022 |g number:4 |g day:14 |g month:04 |g pages:2030-2041 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41380-022-01458-1 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 27 |j 2022 |e 4 |b 14 |c 04 |h 2030-2041 |